| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,846 |
7,044 |
$973K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,038 |
3,609 |
$447K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,795 |
2,254 |
$411K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
798 |
602 |
$242K |
| 70450 |
Computed tomography, head or brain; without contrast material |
775 |
580 |
$216K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,283 |
974 |
$191K |
| 80053 |
Comprehensive metabolic panel |
7,236 |
6,087 |
$151K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,303 |
388 |
$123K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,310 |
2,000 |
$114K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
571 |
377 |
$106K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,072 |
3,680 |
$93K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
272 |
180 |
$85K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
545 |
408 |
$72K |
| 87631 |
|
472 |
360 |
$71K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
474 |
433 |
$71K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,000 |
8,030 |
$66K |
| 80061 |
Lipid panel |
4,103 |
3,706 |
$61K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,170 |
1,983 |
$57K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
447 |
352 |
$56K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
415 |
334 |
$46K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,550 |
2,702 |
$38K |
| 84439 |
|
1,446 |
1,275 |
$34K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
360 |
253 |
$33K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,362 |
2,126 |
$31K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
162 |
123 |
$28K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
425 |
388 |
$27K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
562 |
456 |
$25K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
71 |
52 |
$23K |
| 82607 |
|
845 |
750 |
$21K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,666 |
1,334 |
$20K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
355 |
322 |
$19K |
| G0378 |
Hospital observation service, per hour |
253 |
98 |
$19K |
| 36415 |
Collection of venous blood by venipuncture |
10,069 |
7,488 |
$18K |
| 71046 |
Radiologic examination, chest; 2 views |
721 |
580 |
$15K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
50 |
45 |
$14K |
| 76801 |
|
119 |
82 |
$14K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
93 |
93 |
$13K |
| 86803 |
|
509 |
452 |
$13K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
541 |
439 |
$12K |
| 82570 |
|
978 |
881 |
$12K |
| 82728 |
|
684 |
612 |
$11K |
| 86592 |
|
357 |
312 |
$11K |
| 83540 |
|
887 |
800 |
$11K |
| 83880 |
|
760 |
596 |
$9K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
33 |
24 |
$9K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
266 |
225 |
$9K |
| 84153 |
|
457 |
412 |
$8K |
| 86850 |
|
291 |
217 |
$8K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
167 |
141 |
$7K |
| 86038 |
|
228 |
199 |
$7K |
| J3490 |
Unclassified drugs |
612 |
364 |
$7K |
| 83735 |
|
1,201 |
881 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,135 |
710 |
$7K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
304 |
262 |
$7K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
98 |
70 |
$7K |
| 84481 |
|
437 |
388 |
$6K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
151 |
129 |
$6K |
| 87077 |
|
524 |
438 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
311 |
267 |
$6K |
| 82043 |
|
743 |
688 |
$6K |
| 87070 |
|
316 |
274 |
$5K |
| 86900 |
|
353 |
267 |
$5K |
| 0011A |
|
144 |
134 |
$4K |
| 0012A |
|
121 |
119 |
$4K |
| 83550 |
|
426 |
377 |
$4K |
| 87390 |
|
160 |
133 |
$4K |
| 86703 |
|
175 |
147 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
325 |
269 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,907 |
1,445 |
$3K |
| 71045 |
Radiologic examination, chest; single view |
1,385 |
1,016 |
$3K |
| 85652 |
|
469 |
397 |
$3K |
| 86140 |
|
385 |
340 |
$3K |
| 83970 |
|
108 |
101 |
$3K |
| 73630 |
|
207 |
161 |
$3K |
| 76830 |
Ultrasound, transvaginal |
94 |
74 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
184 |
141 |
$3K |
| 86901 |
|
338 |
254 |
$2K |
| 87480 |
|
169 |
140 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,142 |
1,458 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,181 |
919 |
$2K |
| 82746 |
|
205 |
183 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
345 |
238 |
$2K |
| 85610 |
|
599 |
420 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,623 |
1,093 |
$2K |
| 81001 |
|
1,675 |
1,296 |
$2K |
| 84484 |
|
1,249 |
905 |
$2K |
| 83690 |
|
1,222 |
916 |
$2K |
| 76642 |
|
15 |
13 |
$2K |
| 93017 |
|
20 |
14 |
$2K |
| 87660 |
|
169 |
140 |
$2K |
| 73562 |
|
64 |
49 |
$2K |
| 80320 |
|
108 |
77 |
$2K |
| 99201 |
|
12 |
12 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
151 |
129 |
$2K |
| 84403 |
|
80 |
74 |
$2K |
| 81003 |
|
1,165 |
906 |
$2K |
| 86431 |
|
77 |
69 |
$1K |
| 87186 |
|
282 |
241 |
$1K |
| 87510 |
|
169 |
140 |
$1K |
| 84702 |
|
82 |
51 |
$1K |
| 84550 |
|
171 |
148 |
$1K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
134 |
68 |
$1K |
| 80076 |
|
43 |
38 |
$886.90 |
| 73610 |
|
120 |
104 |
$858.80 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,476 |
1,633 |
$840.70 |
| 96376 |
|
164 |
94 |
$776.40 |
| 85007 |
|
115 |
93 |
$704.16 |
| 97162 |
|
15 |
13 |
$587.60 |
| 85379 |
|
204 |
159 |
$556.74 |
| 73030 |
|
15 |
12 |
$499.26 |
| 81025 |
|
1,393 |
989 |
$488.11 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
89 |
79 |
$480.93 |
| 73130 |
|
34 |
28 |
$423.94 |
| 84156 |
|
79 |
70 |
$410.24 |
| 82947 |
|
28 |
28 |
$409.66 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
955 |
616 |
$381.70 |
| 86618 |
|
12 |
12 |
$221.64 |
| 87040 |
|
141 |
100 |
$203.82 |
| 83605 |
|
134 |
86 |
$203.20 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
17 |
13 |
$186.67 |
| 80305 |
|
103 |
64 |
$148.52 |
| 73110 |
|
14 |
13 |
$108.97 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
421 |
255 |
$101.73 |
| 90715 |
|
13 |
13 |
$99.19 |
| 82962 |
|
289 |
248 |
$99.08 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
344 |
274 |
$94.48 |
| 85730 |
|
30 |
25 |
$85.72 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,180 |
790 |
$84.59 |
| J2704 |
Injection, propofol, 10 mg |
647 |
431 |
$57.18 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,858 |
1,225 |
$54.85 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
186 |
135 |
$29.74 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
29 |
26 |
$26.18 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
67 |
38 |
$23.61 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
592 |
357 |
$22.79 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$17.97 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
97 |
56 |
$17.71 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
493 |
295 |
$13.17 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
260 |
168 |
$13.14 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
412 |
234 |
$3.05 |
| 91301 |
|
244 |
233 |
$2.34 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
84 |
51 |
$1.04 |
| 1159F |
|
199 |
167 |
$0.00 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
119 |
65 |
$0.00 |
| 3288F |
|
95 |
87 |
$0.00 |
| 3078F |
|
522 |
480 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
54 |
52 |
$0.00 |
| 00731 |
|
32 |
29 |
$0.00 |
| 1160F |
|
199 |
167 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
76 |
65 |
$0.00 |
| 76937 |
|
31 |
24 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
38 |
26 |
$0.00 |
| 3077F |
|
12 |
12 |
$0.00 |
| 3074F |
|
1,016 |
940 |
$0.00 |
| 3008F |
|
1,297 |
1,184 |
$0.00 |
| 1036F |
|
883 |
796 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
86 |
69 |
$0.00 |
| 3079F |
|
462 |
428 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
36 |
24 |
$0.00 |
| 4010F |
|
15 |
13 |
$0.00 |
| 1034F |
|
132 |
121 |
$0.00 |
| 3075F |
|
27 |
24 |
$0.00 |